Side-by-side comparison of AI visibility scores, market position, and capabilities
$12.5M round in Jan 2026 led by Lightspeed and Z47. Uses AI to automate back-office workflows around legacy healthcare systems like faxes and EDI.
Coral Health applies AI to automate healthcare back-office workflows that still run on legacy infrastructure — fax machines, EDI feeds, manual eligibility checks, and prior authorization paperwork. The bet is that AI can wrap existing legacy systems rather than replace them, capturing the majority of the value without forcing provider or payer rip-and-replace cycles.
Revvity (RVTY) reported ~$2.9B revenue in FY2024. Life science tools and diagnostics company providing instruments, reagents, and software for genomics, newborn screening, and drug discovery. HQ: Waltham, MA.
Revvity, Inc. (formerly PerkinElmer) is a global life science tools and diagnostics company, rebranded in 2023 to signal its transformation from a diversified instruments company into a focused provider of solutions for reproductive health, genomics, and applied markets. The company operates in two segments: Life Sciences (analytical instruments, reagents, software for pharmaceutical and academic research) and Diagnostics (immunoassay and molecular diagnostic systems for clinical and screening applications). Revvity is the global leader in newborn screening, processing the tests that check newborns for metabolic and genetic disorders shortly after birth.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.